Northern Trust Corp Viridian Therapeutics, Inc.\De Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Northern Trust Corp holds 581,608 shares of VRDN stock, worth $11.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

581,608

Previous 479,881 21.2%

Holding current value

$11.5 Million

Previous $6.24 Million 111.93%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$12.16 - $23.33 $1.24 Million - $2.37 Million	101,727 Added 21.2%	581,608 $13.2 Million
Q2 2024 Aug 14, 2024	BUY	$11.6 - $17.26 $199,531 - $296,889	17,201 Added 3.72%	479,881 $6.24 Million
Q1 2024 May 14, 2024	BUY	$17.09 - $23.82 $838,076 - $1.17 Million	49,039 Added 11.86%	462,680 $8.1 Million
Q4 2023 Feb 13, 2024	BUY	$11.12 - $22.5 $133,162 - $269,437	11,975 Added 2.98%	413,641 $9.01 Million
Q3 2023 Nov 13, 2023	SELL	$15.16 - $24.7 $63,656 - $103,715	-4,199 Reduced 1.03%	401,666 $6.16 Million
Q2 2023 Aug 11, 2023	BUY	$22.57 - $29.67 $788,573 - $1.04 Million	34,939 Added 9.42%	405,865 $9.66 Million
Q1 2023 May 15, 2023	BUY	$25.04 - $37.6 $231,294 - $347,311	9,237 Added 2.55%	370,926 $9.44 Million
Q4 2022 Feb 13, 2023	BUY	$18.78 - $29.74 $1.67 Million - $2.64 Million	88,878 Added 32.58%	361,689 $10.6 Million
Q3 2022 Nov 14, 2022	BUY	$10.7 - $25.5 $308,748 - $735,802	28,855 Added 11.83%	272,811 $5.6 Million
Q2 2022 Aug 12, 2022	BUY	$9.55 - $19.0 $1.79 Million - $3.56 Million	187,469 Added 331.88%	243,956 $2.82 Million
Q1 2022 May 13, 2022	SELL	$16.79 - $20.88 $47,700 - $59,320	-2,841 Reduced 4.79%	56,487 $1.04 Million
Q4 2021 Feb 08, 2022	BUY	$15.65 - $21.5 $386,195 - $530,555	24,677 Added 71.22%	59,328 $1.17 Million
Q3 2021 Nov 15, 2021	BUY	$10.69 - $18.2 $34,036 - $57,948	3,184 Added 10.12%	34,651 $570,000
Q2 2021 Aug 13, 2021	BUY	$14.34 - $18.67 $451,236 - $587,488	31,467 New	31,467 $576,000

Others Institutions Holding VRDN

# of Institutions

179

Shares Held

76.8M

Call Options Held

581K

Put Options Held

439K

View Full List

About Viridian Therapeutics, Inc.\DE

Ticker VRDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,888,900
Market Cap $789M
Description
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...

More about VRDN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Viridian Therapeutics, Inc.\De Transaction History